Our internal protocol is being monitored by our clinical team, and we will transition to patient-facing availability only when we are satisfied with our own observations and with the emerging evidence base
Improved formulations: Sustained-release peptide formulations reducing injection frequency currently in development
The MHRA may consider the substance, claims, imagery, instructions, commercial context and likely intended use
IMPORTANT: Why We Do Not Sell "Pre-Blended" Vials
Be mindful of your mental health, communicate effectively with providers, and make decisions one step at a time instead of engaging in reckless self-treatment
A single-peptide BPC-157 protocol starts at a 1-cycle level with 2- and 3-cycle options that bring the per-cycle cost down